Unlocking the Secrets of Chronic Illness
After decades of mystery and uncertainty, PridCor has harnessed insights from the pandemic response to finally reverse these debilitating Post-Viral Syndromes.
At PridCor Therapeutics, our mission is inspired by the legendary Gordian Knot, a seemingly impossible puzzle symbolizing humanity’s most complex medical challenges. Much like the Gordian Knot, conditions such as Long COVID, Fibromyalgia, ME/CFS, and IBS have resisted understanding and effective treatment, leaving countless lives disrupted.
Driven by relentless curiosity and groundbreaking science, PridCor is committed to unraveling these intricate mysteries. Our logo represents not just our ambition, but our promise: to untie the complexities behind post-viral syndromes, delivering clarity, healing, and renewed hope to those who suffer.
Together, we’re redefining the boundaries of what medicine can achieve—turning the once impossible into tangible recovery.
‎
Pharmaceutical companies and academic research centers have long struggled with expensive, time-consuming, single-agent clinical trials that frequently fail to unravel complex chronic ailments such as Fibromyalgia, ME/CFS, IBS, and now Long COVID. These traditional approaches have fallen short of addressing the true underlying causes of these persistent conditions, leaving millions without effective treatment or hope.
Founded by Dr. William Pridgen, a distinguished physician, researcher, and surgeon with over 35 years of medical innovation and clinical experience, PridCor Therapeutics was established to challenge the status quo. Throughout his career, Dr. Pridgen has relentlessly pursued effective treatments and cures for complicated illnesses largely ignored by conventional markets, continually seeking unique and practical solutions to genuine healthcare delivery barriers.
Leveraging this deep clinical insight and decades of dedicated research, PridCor Therapeutics has developed specialized therapies designed explicitly to address the root causes of post-viral syndromes and chronic conditions. Our precise, revolutionary approach not only unlocks the mystery behind Long COVID but also provides powerful insights and solutions for other notoriously complex “Gordian Knot” conditions, including Fibromyalgia, ME/CFS, and IBS.
At PridCor Therapeutics, we are committed to transforming the landscape of chronic illness treatment—providing effective, evidence-based, and groundbreaking therapeutic strategies to finally bring relief and recovery to those who need it most.
“Traditionally, medical research advances slowly, in small, incremental steps—science often progresses one funeral at a time. At PridCor Therapeutics, we see the Gordian Knot not just as legend, but as an urgent call for radical change. Our bold new philosophy challenges future biotech companies to pursue groundbreaking leaps forward rather than incremental progress.”
Our lead candidate is a fixed dose of valacyclovir, celecoxib, and a third element designed to act as a dual-action therapy. It’s designed to suppress latent viral reactivation and reduce inflammation—two potential drivers of Long COVID.
PridCor’s PCT Trocar Lock represents the future of surgical precision and patient safety. Our custom-designed, 3D-printed device provides unmatched stability and reliability, offering surgeons enhanced control, improved outcomes, and greater procedural efficiency through advanced, personalized technology.
‎
At PridCor Therapeutics, we’re redefining post-viral recovery through scientific innovation. Our lead therapy known as The PridCor Protocol is a proprietary combination of 3 elements including valacyclovir, and celecoxib that is designed to suppress viral reactivation and reduce systemic inflammation which are two key biological drivers of Long COVID.
At PridCor Therapeutics, we’re addressing critical gaps in pharyngitis treatment through groundbreaking innovation. Our proprietary throat spray, PCT-1, uniquely adheres to the posterior pharynx, consistently delivering therapeutic medication—even after repeated swallows. Ideal for routine cases of pharyngitis and invaluable for cancer patients suffering from oral mucositis during head and neck radiation therapy, PCT-1 represents a first-of-its-kind advancement in therapeutic throat care.
At PridCor Therapeutics, we’re eliminating common frustrations associated with robotic, laparoscopic, and minimally invasive procedures. Traditional trocars can slip deeper into the abdomen, impairing visualization and restricting surgical instrument movement—prolonging surgery and increasing surgeon frustration. Our proprietary, custom-designed PCT Trocar Lock attachment prevents trocar slippage, enabling smoother, more efficient, and precise surgical operations.
Leadership Rooted in Clinical Experience and Scientific Vision
Founder & Chief Executive Officer
Tuscaloosa, Alabama
Successfully Founded Virios Therapeutics now trading as Dogwood Therapeutics on the NASDAQ.
Dr. Pridgen is a board-certified surgeon and the originator of the PridCor Protocol, a novel therapy based on a fixed dose of valacyclovir, celecoxib, and a third element, developed to address the biological underpinnings of Long COVID. With more than 20 years of clinical experience, he brings a unique perspective to pharmaceutical innovation—where real-world patient insight meets rigorous science.
‎
Recognitions
‎
đź“Ť Headquarters: Tuscaloosa, AL
📧 Email: info@pridcor.com
đź“ž Phone: 205-366-0696
